Zurich Cantonal Bank’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-894
Closed -$55K 2923
2022
Q1
$55K Buy
894
+800
+851% +$65.9K ﹤0.01% 2503
2021
Q4
$12K Sell
94
-10
-10% -$1.63K ﹤0.01% 2887
2021
Q3
$21K Hold
104
﹤0.01% 2778
2021
Q2
$28K Buy
104
+8
+8% +$2.48K ﹤0.01% 2551
2021
Q1
$34K Buy
+96
New +$41K ﹤0.01% 2483

Other funds holding PASG

Zurich Cantonal Bank's PASG Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 894 shares — an estimated $55K sold.

Zurich Cantonal Bank first reported a position in PASG in Q1 2021 and held it in 5 quarters. The position peaked at $55K in Q1 2022. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Zurich Cantonal Bank reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 894 Passage Bio shares in Q2 2022, an estimated $55K.
  • Zurich Cantonal Bank first reported a position in Passage Bio in Q1 2021 and held it in 5 quarters.
  • Zurich Cantonal Bank's Passage Bio position peaked at $55K in Q1 2022.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.